Byrna Technologies Inc. (NASDAQ: BYRN) ("Byrna" or "the Company") today announced preliminary revenue expectations for its fiscal fourth quarter ended November 30, 2022 ("Q4 FY2022") of $16.0...

ReImagine Science, a non-profit focused on transforming the way science is done, is innovating once again with a workshop co-designed with a renowned member of the North American First Nations....

Industry-leading Indices Available with Athene® BCA® Result in Award SCOTTSDALE, Ariz., Dec. 6, 2022 /PRNewswire/ -- Annexus, a leading retirement product design company, announced that Athene...

CEO Eric Finzi and COO Sebastian De Beurs to present on company's innovative neuromodulators for mental health at annual healthcare conference NEWPORT BEACH, Calif., Dec. 6, 2022 /PRNewswire/ --...

P-MUC1C-ALLO1 and P-BCMA-ALLO1 were well tolerated, with no dose-limiting toxicities (DLTs), cytokine release syndrome (CRS), graft vs host disease (GVHD) or immune effector cell-associated...